116 related articles for article (PubMed ID: 7427883)
1. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
Zimmerman R; Wahren B; Edsmyr F
Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
[TBL] [Abstract][Full Text] [Related]
2. Urinary CEA for prediction of survival time and recurrence in bladder cancer.
Wahren B; Nilsson B; Zimmerman R
Cancer; 1982 Jul; 50(1):139-45. PubMed ID: 7083117
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
Wahren B; Edsmyr F; Zimmerman R
Cancer; 1975 Oct; 36(4):1490-5. PubMed ID: 1175143
[TBL] [Abstract][Full Text] [Related]
4. Urine carcinoembryonic antigen determination in urinary bladder bilharziasis predicts carcinoma in patients with premalignant lesions: observation of 43 cases in Egypt.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
Tanzan Health Res Bull; 2006 Sep; 8(3):122-7. PubMed ID: 18254501
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a double-monoclonal radioimmunoassay for the measurement of carcinoembryonic antigen in the urine of patients with bladder cancer.
Hetherington JW; Ewing R; Cooper EH
Eur Urol; 1986; 12(4):270-3. PubMed ID: 3743597
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen in serum, urine and cells of patients with bladder carcinoma.
Wahren B; Edsmyr F
Urol Res; 1978; 6(4):221-4. PubMed ID: 369085
[TBL] [Abstract][Full Text] [Related]
7. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
[TBL] [Abstract][Full Text] [Related]
8. Urinary carcinoembryogenic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma.
Tailly G; Cornelissen M; Vereecken RL; Verduyn H; Devos P; De Roo M
Br J Urol; 1983 Oct; 55(5):501-7. PubMed ID: 6626896
[TBL] [Abstract][Full Text] [Related]
9. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen in urine in patients with urothelial carcinoma. An expression for the extent of inflammatory reaction of the urinary tract.
Colleen S; Ek A; Gullberg B; Johansson BG; Lindberg LG; Olsson AM
Scand J Urol Nephrol; 1979; 13(2):149-53. PubMed ID: 482866
[TBL] [Abstract][Full Text] [Related]
11. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
12. Prediction of survival and recurrence in bladder carcinoma.
Nilsson B; Wahren B; Esposti PL; Edsmyr F
Urol Res; 1982; 10(3):109-13. PubMed ID: 7135696
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of urinary CEA measurement as a screening test of bladder cancer (author's transl)].
Oshiumi Y; Yagi H; Nishitani H; Yamawaki H; Nakayama C; Kamoi I; Matsuura K; Momose S
Radioisotopes; 1979 Jun; 28(6):367-70. PubMed ID: 531259
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
[TBL] [Abstract][Full Text] [Related]
17. [Elevated CEA values after cystectomy for bladder cancer and intestinal urinary diversion not evidence of tumor recurrence].
Klippel KF; Axt D; Schärfe T; Preiss J; Alves de Oliveira CR
Onkologie; 1983 Jun; 6(3):126, 127-31. PubMed ID: 6350964
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma.
Korsten CB; Persijn JP; Renaud J
Br J Cancer; 1974 Aug; 30(2):174-5. PubMed ID: 4419334
[No Abstract] [Full Text] [Related]
19. Non-invasive molecular detection of bladder cancer recurrence.
Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
